Trial Profile
Randomized, Phase II Trial of Atorvastatin, RAFTILOSE Synergy 1, and Sulindac Among Patients at Increased Risk for Sporadic Colorectal Neoplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Inulin (Primary) ; Sulindac (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 03 Jul 2010 Results reported at 12th World Congress on Gastrointestinal Cancer.
- 03 May 2010 Results presented at the Digestive Disease Week 2010.
- 05 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.